RefuelBio ApS
Core data
Name | RefuelBio ApS |
Address | Nordre Fasanvej 215, 2000, Frederiksberg |
Founded | Jul 1, 2024 |
Employees (CVR) | 4 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | RefuelBio ApS |
Address | Nordre Fasanvej 215, 2000, Frederiksberg |
Founded | Jul 1, 2024 |
Employees (CVR) | 4 |
Locations (P-units) | 1View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of RefuelBio ApS
Description
RefuelBio ApS’ primary activity consists of early-stage research and development of a novel medical drug candidate aimed at preventing muscle loss. The Company focuses on conditions where weight loss is accompanied by muscle loss, including obesity, type 2 diabetes, and other related medical indications. At present, the Company does not generate significant commercial revenue, as its activities are primarily related to research and development.
Financials
| Reporting period | 2025DKK | |
|---|---|---|
| Gross profit | -13,452,308 | |
| Operating profit | -14,170,662 | |
| Profit before tax | -13,736,161 | |
| Net income | -10,526,976 | |
| Total assets | 23,133,856 | |
| Equity | 20,574,053 | |
| Avg. employees | 1 | |
2024–2025 Unlock financial history | ||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
No contact details have been registered for this company.
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Emmanuelle Coutanceau | Roles Board | TitlesBESTYRELSESMEDLEM |
| Gabor Gyulveszi | Roles Board | TitlesBESTYRELSESMEDLEM |
| Thomas Gundelund Rasmussen | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| EY Godkendt Revisionspartnerselskab | AuditorAnders Roe Eriksen | RoleState Authorised Public Accountant | FromJun 18, 2026 |
| EY Godkendt Revisionspartnerselskab | AuditorRasmus Bloch Jespersen | RoleState Authorised Public Accountant | FromJun 18, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership66.67–89.99 % | Voting rights66.67 % | FromJun 23, 2025 | |
Unknown Other Participant | Ownership25–33.32 % | Voting rights25 % | FromApr 24, 2026 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| NOVO NORDISK FONDEN | Ownership through | 66.67–89.99 % |
| 🇺🇸Age1 Fund I, LP | Ownership through Direct | 25–33.32 % |